News
Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases.
After her daughter's PFIC diagnosis, Claire Brinkley searched for a way to connect with other parents with similar experiences and questions.
The offerings, aimed at improving patient communication, have been developed by intelligent commerce and customer service software provider, Novomind MEA.
The Abu Dhabi-based company is reportedly in talks to co-develop a COVID-19 test that can detect positive cases of the coronavirus from exhaled nasal air.
The aim of the electronic system is to ensure medicines are dispensed according to the correct procedures set by authorities, as well as to prevent counterfeit drugs.
Project will use HIMSS Digital Health Indicator to create roadmap for health services in Queensland…
The initiative aims to drive digital transformation across the state and identify services in need of investment.
Healthcare IT News spoke to nursing and informatics experts to find out how exactly nurses have led the digital transition.
Velissaris said investing in women and people of color helps bring new ideas to the table.
Also: Centauri Health Solutions acquires HCFS; UCSF researchers detail smartphone PPG-based diabetes detection.
The patient-facing EASE app is HIPAA compliant, and does not save any texts, photos or videos to the recipient's device.